
Trump’s 100% Tariff on Pharma Imports
US President Donald Trump has announced a 100% tariff on branded and patented pharmaceutical imports starting October 1, 2025, unless companies build manufacturing plants in the US. This move aims to boost domestic manufacturing, reduce reliance on foreign suppliers and promote national security. The tariff could impact Indian pharma exports, worth $8.7 billion in FY24, and lead to higher drug prices in the US.
September 26, 2025
No Comments
